Table 1 Baseline Characteristics of Study Population
From: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
Variable | % (n) |
|---|---|
Sex | Â |
Female | 64.38 (1,706) |
Male | 35.62 (944) |
Age (years) | Â |
< 15 | 6.26 (144) |
16-45 | 80.0 (2120) |
> 45 | 13.74 (364) |
Baseline CD4 | Â |
< = 200 | 58.72 (1556) |
200 - 350 | 26.68 (707) |
> 350 | 14.60 (387) |
Median baseline CD4 (IQR) | 172 (85-275) |
Baseline WHO Staging* | Â |
Stage I | 27.36 (725) |
Stage II | 26.60 (705) |
Stage III | 40.23 (1066) |
Stage IV | 4.08 (108) |
ART Regimen | Â |
NRTI Backbone | Â |
Zidovudine based | 51.85 (1374) |
Stavudine based | 46.15 (1223) |
Tenofovir based | 1.74 (46) |
Others | 0.26 (7) |
NNRTI Backbone | Â |
Nevirapine_based | 80.04 (2121) |
Efavirenze_based | 19.96 (529) |